We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+563.35%
AUM
$34.1B
AUM Growth
+$1.63B
(+5%)
Cap. Flow
-$169M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,892
New
86
Increased
671
Reduced
778
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$92.1M |
| 2 |
Aaon
AAON
|
+$55.5M |
| 3 |
P
Everpure Inc
P
|
+$43.5M |
| 4 |
Booz Allen Hamilton
BAH
|
+$29M |
| 5 |
RBC Bearings
RBC
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$128M |
| 2 |
CrowdStrike
CRWD
|
+$42.9M |
| 3 |
Blackrock
BLK
|
+$42M |
| 4 |
CoStar Group
CSGP
|
+$41.5M |
| 5 |
Starbucks
SBUX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 12.67% |
| 4 | Industrials | 11.93% |
| 5 | Consumer Discretionary | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Keysight
KEYS
$58.3B
| $2.24M | 0.01% |
14,085
+2,734
| +24% | +$389K |
|
677
Snap-on
SNA
$21.5B
| $2.22M | 0.01% |
7,669
-216
| -3% | -$59.5K |
|
678
Affiliated Managers Group
AMG
$9.76B
| $2.22M | 0.01% |
12,493
-412
| -3% | -$70K |
|
679
Erie Indemnity
ERIE
$13.2B
| $2.21M | 0.01% |
4,090
+180
| +5% | +$81.9K |
|
680
Doximity
DOCS
$4.88B
| $2.21M | 0.01% |
50,634
-49,505
| -49% | -$1.65M |
|
681
T-Mobile US
TMUS
$190B
| $2.2M | 0.01% |
10,667
-4,167
| -28% | -$798K |
|
682
Schwab US Large- Cap ETF
SCHX
$74.6B
| $2.19M | 0.01% |
96,984
-1,026
| -1% | -$22.4K |
|
683
Innovator US Small Cap Power Buffer ETF July
KJUL
$226M
| $2.19M | 0.01% |
75,161
+32,362
| +76% | +$920K |
|
684
Estee Lauder
EL
$32B
| $2.19M | 0.01% |
21,940
-46,347
| -68% | -$4.39M |
|
685
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
| $2.18M | 0.01% |
47,957
+17,863
| +59% | +$785K |
|
686
Eversource Energy
ES
$27.2B
| $2.17M | 0.01% |
31,906
+53
| +0.2% | +$3.42K |
|
687
iShares MSCI Japan ETF
EWJ
$22.8B
| $2.16M | 0.01% |
30,255
-4,415
| -13% | -$307K |
|
688
Williams Companies
WMB
$86.1B
| $2.16M | 0.01% |
47,371
-298
| -0.6% | -$13.1K |
|
689
ARK Innovation ETF
ARKK
$6.29B
| $2.15M | 0.01% |
45,269
-1,504
| -3% | -$67.6K |
|
690
Regeneron Pharmaceuticals
REGN
$80.8B
| $2.15M | 0.01% |
2,043
+58
| +3% | +$64.5K |
|
691
Baxter International
BAX
$14.2B
| $2.13M | 0.01% |
56,211
-3,394
| -6% | -$125K |
|
692
Strategy Inc
MSTR
$38.4B
| $2.13M | 0.01% |
12,635
+295
| +2% | +$42.2K |
|
693
Campbell Soup
CPB
$6.87B
| $2.13M | 0.01% |
43,522
-347
| -0.8% | -$16.9K |
|
694
Jack Henry & Associates
JKHY
$11.1B
| $2.12M | 0.01% |
12,018
+842
| +8% | +$142K |
|
695
Wintrust Financial
WTFC
$10.7B
| $2.12M | 0.01% |
19,524
+394
| +2% | +$41.1K |
|
696
AMN Healthcare
AMN
$1.4B
| $2.11M | 0.01% |
49,724
+14,366
| +41% | +$753K |
|
697
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
| $2.11M | 0.01% |
33,055
-1,063
| -3% | -$63.7K |
|
698
Cellebrite
CLBT
$3.99B
| $2.09M | 0.01% |
124,043
+84,605
| +215% | +$1.26M |
|
699
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $2.08M | 0.01% |
43,864
-5,568
| -11% | -$251K |
|
700
QuidelOrtho
QDEL
$838M
| $2.08M | 0.01% |
45,614
-1,151
| -2% | -$46.6K |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2024 Portfolio in Review
As of Q3 2024, William Blair & Company held 1,892 positions worth $34.1B, up 5% from $32.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q3 2024 filing shows 86 new, 671 increased, 778 reduced and 71 closed positions. Its largest new stake was PAR Technology: 73,733 shares worth $3.84M. The largest sale was DexCom, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q3 2024 buy was PAR Technology: 73,733 shares worth $3.84M.
- William Blair & Company added most to NVIDIA in Q3 2024, an estimated $92.1M increase.
- William Blair & Company's biggest Q3 2024 reduction was DexCom, cutting an estimated $128M.
- William Blair & Company fully exited Blackrock in Q3 2024, selling an estimated $42M.
- William Blair & Company's ten largest holdings make up 24% of its $34.1B portfolio in Q3 2024.
- William Blair & Company opened 86 new positions and closed 71 in Q3 2024.
- William Blair & Company's portfolio value rose 5% quarter-over-quarter to $34.1B.
Based on William Blair & Company's 13F filing for Q3 2024, filed 12 Nov 2024.